unilabs limited Company Information
Company Number
04115820
Website
http://www.unilabs.co.ukRegistered Address
24-32 stephenson way, london, NW1 2HD
Industry
Other human health activities
Telephone
02072994490
Next Accounts Due
35 days late
Group Structure
View All
Shareholders
unilabs holding ltd 100%
unilabs limited Estimated Valuation
Pomanda estimates the enterprise value of UNILABS LIMITED at £11.6m based on a Turnover of £15.4m and 0.76x industry multiple (adjusted for size and gross margin).
unilabs limited Estimated Valuation
Pomanda estimates the enterprise value of UNILABS LIMITED at £0 based on an EBITDA of £-987k and a 6.63x industry multiple (adjusted for size and gross margin).
unilabs limited Estimated Valuation
Pomanda estimates the enterprise value of UNILABS LIMITED at £8.2m based on Net Assets of £3.5m and 2.38x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Unilabs Limited Overview
Unilabs Limited is a live company located in london, NW1 2HD with a Companies House number of 04115820. It operates in the other human health activities sector, SIC Code 86900. Founded in November 2000, it's largest shareholder is unilabs holding ltd with a 100% stake. Unilabs Limited is a mature, mid sized company, Pomanda has estimated its turnover at £15.4m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Unilabs Limited Health Check
Pomanda's financial health check has awarded Unilabs Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 5 areas for improvement. Company Health Check FAQs
6 Strong
1 Regular
5 Weak
Size
annual sales of £15.4m, make it larger than the average company (£851k)
£15.4m - Unilabs Limited
£851k - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a faster rate (4.7%)
6% - Unilabs Limited
4.7% - Industry AVG
Production
with a gross margin of 37.2%, this company has a comparable cost of product (35%)
37.2% - Unilabs Limited
35% - Industry AVG
Profitability
an operating margin of -14.8% make it less profitable than the average company (7.5%)
-14.8% - Unilabs Limited
7.5% - Industry AVG
Employees
with 92 employees, this is above the industry average (20)
92 - Unilabs Limited
20 - Industry AVG
Pay Structure
on an average salary of £40.2k, the company has a higher pay structure (£24.7k)
£40.2k - Unilabs Limited
£24.7k - Industry AVG
Efficiency
resulting in sales per employee of £167.1k, this is more efficient (£48.3k)
£167.1k - Unilabs Limited
£48.3k - Industry AVG
Debtor Days
it gets paid by customers after 78 days, this is later than average (24 days)
78 days - Unilabs Limited
24 days - Industry AVG
Creditor Days
its suppliers are paid after 40 days, this is slower than average (16 days)
40 days - Unilabs Limited
16 days - Industry AVG
Stock Days
it holds stock equivalent to 6 days, this is less than average (9 days)
6 days - Unilabs Limited
9 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (106 weeks)
0 weeks - Unilabs Limited
106 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 75.5%, this is a higher level of debt than the average (26.7%)
75.5% - Unilabs Limited
26.7% - Industry AVG
UNILABS LIMITED financials
Unilabs Limited's latest turnover from December 2022 is £15.4 million and the company has net assets of £3.5 million. According to their latest financial statements, Unilabs Limited has 92 employees and maintains cash reserves of £61.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 15,372,465 | 13,634,300 | 10,555,237 | 12,756,527 | 12,012,073 | 12,271,512 | 11,819,829 | 10,557,026 | 9,021,788 | 9,985,676 | 9,391,057 | 8,661,392 | 7,961,386 | 7,400,109 |
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost Of Sales | 9,654,346 | 8,572,569 | 6,189,263 | 6,730,651 | 6,565,278 | 7,246,193 | 6,992,374 | 6,085,886 | 5,292,675 | 5,510,849 | 5,199,204 | 4,815,145 | 4,268,376 | 3,901,895 |
Gross Profit | 5,718,119 | 5,061,731 | 4,365,974 | 6,025,876 | 5,446,795 | 5,025,319 | 4,827,455 | 4,471,140 | 3,729,113 | 4,474,827 | 4,191,853 | 3,846,247 | 3,693,010 | 3,498,214 |
Admin Expenses | 7,998,019 | 6,573,978 | 5,212,242 | 5,847,045 | 5,347,360 | 5,175,761 | 3,574,358 | 3,736,668 | 3,025,009 | 3,450,781 | 3,486,560 | 3,797,021 | 3,232,397 | 2,569,968 |
Operating Profit | -2,279,900 | -1,512,247 | -846,268 | 178,831 | 99,435 | -150,442 | 1,253,097 | 734,472 | 704,104 | 1,024,046 | 705,293 | 49,226 | 460,613 | 928,246 |
Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 129 | 0 | 0 | 1,357 | 0 | 0 | 0 | |
Interest Receivable | 92,155 | 113,941 | 131,635 | 129,525 | 128,532 | 150,626 | 120,013 | 57,389 | 67,465 | 24,047 | 2,522 | 432 | 0 | 2,200 |
Pre-Tax Profit | -2,187,745 | -1,398,306 | -714,633 | 308,356 | 227,967 | 184 | 1,372,981 | 791,861 | 771,569 | 1,046,736 | 707,815 | 49,658 | 460,613 | 930,446 |
Tax | -519,168 | 217,570 | -91,709 | -7,417 | 2,730 | -190,660 | -249,884 | -142,886 | -146,582 | -213,676 | -157,623 | 21,707 | -37,467 | -167,398 |
Profit After Tax | -2,706,913 | -1,180,736 | -806,342 | 300,939 | 230,697 | -190,476 | 1,123,097 | 648,975 | 624,987 | 833,060 | 550,192 | 71,365 | 423,146 | 763,048 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Profit | -2,706,913 | -1,180,736 | -806,342 | 300,939 | 230,697 | -190,476 | 1,123,097 | 648,975 | 624,987 | 833,060 | 550,192 | 71,365 | 423,146 | 763,048 |
Employee Costs | 3,700,477 | 3,700,477 | 3,232,430 | 3,179,731 | 2,995,508 | 3,326,679 | 3,474,534 | 2,929,889 | 3,028,176 | 3,200,594 | 3,371,547 | 3,120,745 | 2,928,540 | 2,819,842 |
Number Of Employees | 92 | 93 | 93 | 84 | 78 | 71 | 62 | 51 | 49 | 51 | 54 | 54 | 57 | 61 |
EBITDA* | -987,028 | -356,691 | 22,114 | 827,898 | 460,752 | 6,749 | 1,410,288 | 907,562 | 865,823 | 1,192,133 | 956,925 | 333,531 | 726,332 | 1,213,622 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 4,107,282 | 4,249,232 | 4,455,578 | 3,190,119 | 3,053,774 | 1,679,016 | 513,843 | 243,014 | 225,571 | 310,305 | 222,661 | 421,696 | 438,061 | 562,930 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 4,107,282 | 4,249,232 | 4,455,578 | 3,190,119 | 3,053,774 | 1,679,016 | 513,843 | 243,014 | 225,571 | 310,305 | 222,661 | 421,696 | 438,061 | 562,930 |
Stock & work in progress | 181,995 | 177,559 | 704,959 | 30,148 | 32,160 | 26,977 | 26,226 | 40,617 | 26,629 | 25,725 | 39,564 | 35,854 | 37,466 | 20,803 |
Trade Debtors | 3,324,798 | 2,374,868 | 3,039,914 | 3,387,976 | 3,170,071 | 3,224,863 | 3,226,038 | 2,473,740 | 1,539,522 | 1,250,915 | 1,598,920 | 1,719,434 | 1,287,790 | 1,035,305 |
Group Debtors | 5,629,536 | 5,250,385 | 5,686,295 | 5,044,597 | 5,190,895 | 5,128,871 | 5,072,857 | 3,730,852 | 3,770,166 | 3,401,145 | 2,249,364 | 2,270,894 | 2,200,000 | 1,100,000 |
Misc Debtors | 804,934 | 743,057 | 1,173,838 | 708,360 | 962,073 | 764,455 | 266,386 | 393,918 | 227,759 | 287,443 | 325,762 | 299,773 | 288,796 | 251,759 |
Cash | 61,359 | 86,021 | 74,560 | 284,376 | 118,996 | 1,555,847 | 1,503,619 | 2,039,842 | 1,538,314 | 1,807,389 | 1,622,952 | 538,499 | 799,057 | 1,496,521 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 10,002,622 | 8,631,890 | 10,679,566 | 9,455,457 | 9,474,195 | 10,701,013 | 10,095,126 | 8,678,969 | 7,102,390 | 6,772,617 | 5,836,562 | 4,864,454 | 4,613,109 | 3,904,388 |
total assets | 14,109,904 | 12,881,122 | 15,135,144 | 12,645,576 | 12,527,969 | 12,380,029 | 10,608,969 | 8,921,983 | 7,327,961 | 7,082,922 | 6,059,223 | 5,286,150 | 5,051,170 | 4,467,318 |
Bank overdraft | 6,260,817 | 3,760,579 | 2,369,656 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 1,084,339 | 1,378,756 | 1,411,411 | 1,416,896 | 700,699 | 633,028 | 556,471 | 542,604 | 482,247 | 446,929 | 513,434 | 601,695 | 382,193 | 192,118 |
Group/Directors Accounts | 54,072 | 16,899 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117,410 | 80,972 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 2,643,666 | 1,470,133 | 3,701,016 | 2,891,819 | 3,767,932 | 3,910,257 | 2,194,348 | 1,669,030 | 784,340 | 1,199,606 | 972,462 | 631,320 | 569,797 | 635,604 |
total current liabilities | 10,042,894 | 6,626,367 | 7,482,083 | 4,308,715 | 4,468,631 | 4,543,285 | 2,750,819 | 2,211,634 | 1,266,587 | 1,646,535 | 1,485,896 | 1,233,015 | 1,069,400 | 908,694 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 30,000 | 30,000 | 30,000 | 30,000 | 0 | 30,000 | 30,000 | 30,000 |
provisions | 616,395 | 97,227 | 314,797 | 192,255 | 215,671 | 223,774 | 24,704 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 616,395 | 97,227 | 314,797 | 192,255 | 215,671 | 223,774 | 54,704 | 30,000 | 30,000 | 30,000 | 0 | 30,000 | 30,000 | 30,000 |
total liabilities | 10,659,289 | 6,723,594 | 7,796,880 | 4,500,970 | 4,684,302 | 4,767,059 | 2,805,523 | 2,241,634 | 1,296,587 | 1,676,535 | 1,485,896 | 1,263,015 | 1,099,400 | 938,694 |
net assets | 3,450,615 | 6,157,528 | 7,338,264 | 8,144,606 | 7,843,667 | 7,612,970 | 7,803,446 | 6,680,349 | 6,031,374 | 5,406,387 | 4,573,327 | 4,023,135 | 3,951,770 | 3,528,624 |
total shareholders funds | 3,450,615 | 6,157,528 | 7,338,264 | 8,144,606 | 7,843,667 | 7,612,970 | 7,803,446 | 6,680,349 | 6,031,374 | 5,406,387 | 4,573,327 | 4,023,135 | 3,951,770 | 3,528,624 |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | -2,279,900 | -1,512,247 | -846,268 | 178,831 | 99,435 | -150,442 | 1,253,097 | 734,472 | 704,104 | 1,024,046 | 705,293 | 49,226 | 460,613 | 928,246 |
Depreciation | 1,292,872 | 1,155,556 | 868,382 | 649,067 | 361,317 | 157,191 | 157,191 | 173,090 | 161,719 | 168,087 | 251,632 | 284,305 | 265,719 | 285,376 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | -519,168 | 217,570 | -91,709 | -7,417 | 2,730 | -190,660 | -249,884 | -142,886 | -146,582 | -213,676 | -157,623 | 21,707 | -37,467 | -167,398 |
Stock | 4,436 | -527,400 | 674,811 | -2,012 | 5,183 | 751 | -14,391 | 13,988 | 904 | -13,839 | 3,710 | -1,612 | 16,663 | 20,803 |
Debtors | 1,390,958 | -1,531,737 | 759,114 | -182,106 | 204,850 | 552,908 | 1,966,771 | 1,061,063 | 597,944 | 765,457 | -116,055 | 513,515 | 1,389,522 | 2,387,064 |
Creditors | -294,417 | -32,655 | -5,485 | 716,197 | 67,671 | 76,557 | 13,867 | 60,357 | 35,318 | -66,505 | -88,261 | 219,502 | 190,075 | 192,118 |
Accruals and Deferred Income | 1,173,533 | -2,230,883 | 809,197 | -876,113 | -142,325 | 1,715,909 | 525,318 | 884,690 | -415,266 | 227,144 | 341,142 | 61,523 | -65,807 | 635,604 |
Deferred Taxes & Provisions | 519,168 | -217,570 | 122,542 | -23,416 | -8,103 | 199,070 | 24,704 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | -1,503,306 | -561,092 | -577,266 | 821,267 | 170,692 | 1,253,966 | -228,087 | 634,672 | -259,555 | 387,478 | 1,164,528 | 124,360 | -593,052 | -533,921 |
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 37,173 | 16,899 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -117,410 | 36,438 | 80,972 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | -30,000 | 0 | 0 | 0 | 30,000 | -30,000 | 0 | 0 | 30,000 |
share issue | ||||||||||||||
interest | 92,155 | 113,941 | 131,635 | 129,525 | 128,532 | 150,626 | 119,884 | 57,389 | 67,465 | 22,690 | 2,522 | 432 | 2,200 | |
cash flow from financing | 129,328 | 130,840 | 131,635 | 129,525 | 128,532 | 120,626 | 119,884 | 57,389 | 67,465 | 52,690 | -27,478 | -116,978 | 2,878,748 | |
cash and cash equivalents | ||||||||||||||
cash | -24,662 | 11,461 | -209,816 | 165,380 | -1,436,851 | 52,228 | -536,223 | 501,528 | -269,075 | 184,437 | 1,084,453 | -260,558 | -697,464 | 1,496,521 |
overdraft | 2,500,238 | 1,390,923 | 2,369,656 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -2,524,900 | -1,379,462 | -2,579,472 | 165,380 | -1,436,851 | 52,228 | -536,223 | 501,528 | -269,075 | 184,437 | 1,084,453 | -260,558 | -697,464 | 1,496,521 |
unilabs limited Credit Report and Business Information
Unilabs Limited Competitor Analysis
Perform a competitor analysis for unilabs limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in NW1 area or any other competitors across 12 key performance metrics.
unilabs limited Ownership
UNILABS LIMITED group structure
Unilabs Limited has no subsidiary companies.
Ultimate parent company
CIDRA SARL
#0071120
2 parents
UNILABS LIMITED
04115820
unilabs limited directors
Unilabs Limited currently has 3 directors. The longest serving directors include Dr Rahul Chaudhary (Oct 2023) and Mr Dhilum Alacon (Feb 2024).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Rahul Chaudhary | England | 47 years | Oct 2023 | - | Director |
Mr Dhilum Alacon | 47 years | Feb 2024 | - | Director | |
Mr Robin Dargue | England | 57 years | Sep 2024 | - | Director |
P&L
December 2022turnover
15.4m
+13%
operating profit
-2.3m
+51%
gross margin
37.2%
+0.19%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
3.5m
-0.44%
total assets
14.1m
+0.1%
cash
61.4k
-0.29%
net assets
Total assets minus all liabilities
unilabs limited company details
company number
04115820
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
November 2000
age
24
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2022
previous names
independent histopathology services limited (September 2008)
accountant
-
auditor
GKP (AMPTHILL) LIMITED
address
24-32 stephenson way, london, NW1 2HD
Bank
-
Legal Advisor
-
unilabs limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 7 charges/mortgages relating to unilabs limited. Currently there are 2 open charges and 5 have been satisfied in the past.
unilabs limited Companies House Filings - See Documents
date | description | view/download |
---|